Is Eli Lilly Stock Headed Toward $1300 Levels? - Nasdaq

Eli Lilly’s stock has seen phenomenal gains of 440% from levels of $160 in early January 2021 to around $860 now, vs. an increase of about 50% for the S&P 500 over this period.

440%
OFF

Is Eli Lilly Stock Headed Toward $1300 Levels? - Nasdaq

2 weeks from now

Eli Lilly’s stock has seen phenomenal gains of 440% from levels of $160 in early January 2021 to around $860 now, vs. an increase of about 50% for the S&P 500 over this period.

nasdaq.com

$1300
OFF

Is Eli Lilly Stock Headed Toward $1300 Levels?

2 weeks from now

Jul 26, 2024 · Eli Lilly logo is screened on a mobile phone for illustration photo. Krakow, Poland on April 9th, … [+] 2024 (Photo by Beata Zawrzel/NurPhoto via Getty Images) NurPhoto via …

unitymarketenterprise.net

$1000
OFF

Eli Lilly Stock Upgraded To "Buy" As Analysts Boost Price Target To …

2 weeks from now

Jan 2, 2025 · A number of other companies have also reaffirmed their belief in Eli Lilly's stock. Truist Financial added its predicted price to improve from $1,000 to $1,033, delivering a 'buy,' …

yahoo.com

$1300
OFF

Is Eli Lilly Stock Headed Toward $1300 Levels? - Reportify

2 weeks from now

Jul 26, 2024 · Eli Lilly logo is screened on a mobile phone for illustration photo. Krakow, Poland on April 9th, ... [+] 2024 (Photo by Beata Zawrzel/NurPhoto via Getty Images)NurPhoto via …

reportify.cc

$1100
OFF

Eli Lilly (LLY) Stock Price Prediction And Forecast 2025-2030

2 weeks from now

21 hours ago · Of the 26 analysts covering Eli Lilly stock, the current rating is 1.67 or “Outperform” with 1-year price targets as high as $1,100 and as low as $540.00. 24/7 Wall Street sets its 1 …

247wallst.com

50%
OFF

Is Eli Lilly Stock Headed Toward $1300 Levels? | Trefis

2 weeks from now

Jul 25, 2024 · Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the broader indices, with the S&P 500 up over 15%. ... Is Eli Lilly Stock …

trefis.com

4%
OFF

Watch These Eli Lilly Price Levels As Stock Sets Record

2 weeks from now

Aug 21, 2024 · Eli Lilly shares were up 0.4% at $954.01 in premarket trading Wednesday about two hours before the opening bell. The stock hit an all-time intraday high of $967 on Tuesday.

investopedia.com

$1250
OFF

Eli Lilly Price Target Raised To $1,250 From $1,060 At Citi

2 weeks from now

Oct 25, 2024 · Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of analyst coverage. GLP-1 adoption has fueled …

nasdaq.com

$540
OFF

After Earnings, Is Eli Lilly Stock A Buy, A Sell, Or Fairly Valued?

2 weeks from now

Aug 15, 2024 · Fair Value Estimate for Eli Lilly. With its 2-star rating, we believe Eli Lilly’s stock is overvalued compared with our long-term fair value estimate of $540.

morningstar.com

$2
OFF

1 Unstoppable Growth Stock Heading To $2 Trillion By 2030

2 weeks from now

Sep 28, 2024 · Eli Lilly's stock price should also be boosted by clinical progress on new medications. Lilly's pipeline is full of exciting products, particularly in the high-flying area of …

nasdaq.com

50%
OFF

Is Eli Lilly Stock Headed Toward $1300 Levels?

2 weeks from now

Aug 23, 2024 · Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the broader indices, with the S&P 500 up over 15%. The stock. ... Is Eli Lilly …

shareandstocks.com

400%
OFF

Up 400% In Three Years Eli Lilly Stock Just Keeps Giving

2 weeks from now

Jun 10, 2024 · Our Why Eli Lilly Stock Moved dashboard has more details. Admirably, LLY stock has outperformed the broader market in each of the last three years. Returns for the stock …

nasdaq.com

10%
OFF

Here's Why Eli Lilly Stock May Continue To See Higher Levels

2 weeks from now

Aug 6, 2021 · The stock price of Eli Lilly (NYSE: LLY) has seen a rise of nearly 10% over the last twenty-one trading days, and it is also up a solid 55% year-to-date. The company recently …

nasdaq.com

FAQs about Is Eli Lilly Stock Headed Toward $1300 Levels? - Nasdaq Coupon?

Is Eli Lilly stock a good buy?

The average target predicts an increase of 26.10% from the current stock price of 777.53. The average analyst rating for Eli Lilly stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market. ...

Is Eli Lilly & Co stock undervalued?

Current stock price is around $803.38, which may be perceived as undervalued given the company's growth prospects and recent analyst target prices ranging from $885.00 to $1,100.00. Investors should be bearish about investing in Eli Lilly and Co for these reasons: ...

What is the price target for Eli Lilly & Company (LLY)?

The highest price target for LLY is $1,250.00, while the lowest price target for LLY is $723.00. The average price target represents a forecasted upside of 27.48% from the current price of $786.15. Enter your email address to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors. ...

Should you buy Eli Lilly (LLY)?

Here's Why You Should Still Buy the Stock. Even a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat, signaling that the market's reception to its financial performance was strongly negative. ...

Will Eli Lilly's earnings grow to $25 in 2027?

Considering our revenue projections and expected margin expansion, $25 in adjusted EPS is likely possible by 2027, as compared to the $6.32 it reported in 2023. Now, if Eli Lilly’s earnings grow to $25, the forward P/E multiple will shrink to 34x in 2026 from its current level, assuming the stock price stays the same, correct? ...

Can Eli Lilly make a $50 billion a year?

Here’s how this is possible. Eli Lilly has seen a stellar run lately given the very high demand for its obesity drug – Zepbound – which, along with its diabetes drug – Mounjaro – is expected to garner $50 billion in annual peak sales. ...